IVF and Fertility

Typical base-cycle fees ~₹1.5–₹2.8 lakh (USD ≈1,800–3,400) excluding add-ons. Services include IVF/ICSI, donor programs, freezing, and genetic testing. Reported success rates ~35–50% per transfer (age/diagnosis dependent). MediHeal coordinates opinions, quotes, visas, travel, and follow-ups.

• Tubal factor, severe male factor (ICSI), endometriosis, anovulation, diminished ovarian reserve, or unexplained infertility.
• Couples/individuals who have not conceived with timed intercourse, IUI, or basic treatments and seek higher success options.
• Patients prepared for multiple cycles to improve cumulative success and who accept realistic outcome counseling.

• Experienced reproductive specialists, embryology labs with digital planning and quality controls.
• Significant savings (often vs. Western pricing) with fast scheduling and clear packages.
• Comprehensive programs: IVF/ICSI, donor oocytes/sperm, embryo freezing, PGT; international patient desks for coordination.

• Center matching by age/diagnosis (e.g., male factor → ICSI-strong labs; advanced age/PGT needs → genetics-enabled labs).
• Itemized quotes (base vs add-ons), medication planning, and calendar mapping to minimize time in-country.
• Full logistics: medical visas, airport transfers, accommodation, interpreters, and tele-follow-ups.

• IVF (Conventional)— Fertilization in lab after egg retrieval; single-embryo transfer preferred.
• ICSI— One sperm injected into each mature egg—useful for severe male factor/prior failed fertilization.
• Donor Programs— Donor eggs/sperm per eligibility and clinic policy; higher success in select cases.
• Embryo Freezing (Vitrification)— Store surplus embryos for FET cycles; supports multi-cycle planning.
• PGT (Genetic Testing)— Screen embryos when clinically indicated; adds cost and lab steps.

1. Pre-arrival

   • Remote review of prior cycles, AMH/FSH, AFC, semen analysis, ultrasound, and medical history.
   • Receive written plan with protocol (antagonist/agonist), medications, monitoring schedule, and cost breakdown.

2. Stimulation & Monitoring (10–14 days)

   • Gonadotropins ± antagonists; serial scans and labs to time trigger.
   • Lifestyle guidance and medication adherence to optimize oocyte yield/quality.

3. Retrieval & Lab

   • Egg retrieval (sedation/anaesthesia), sperm prep; IVF or ICSI performed; embryos cultured to day 3–5.
   • Discuss fresh transfer vs freezing strategy based on labs, lining, and risk profile.

4. Transfer & Two-Week Wait

   • Single-embryo transfer is standard to reduce multiples; luteal support medications as prescribed.
   • β-hCG blood test after ~10–14 days; if positive, early viability scans follow.

1. After Retrieval

   Cramping/bloating for 24–72 hours; light activity and fluids recommended.

2. After Transfer

   Routine daily activity allowed; avoid intense exertion until test; continue prescribed meds.

3. FET Trip

   Often 5–10 days in-country depending on protocol and lining preparation.

• Access to comprehensive IVF/ICSI and lab capabilities with transparent pricing.
• Option for multi-cycle planning, embryo banking, and FET to improve cumulative success.
• Coordinated travel reduces friction for international patients and companions.

• Base cycle usually covers consults, scans, stimulation, retrieval, lab work, and one fresh transfer.
• Add-ons (ICSI/PGT/donor gametes/freezing/FET) materially change totals. Always request itemized quotes (with meds).

• Plan ~2–3 weeks for a fresh cycle (stimulation to transfer). FET trips are often 5–10 days.
• International patients generally use a medical visa; documents typically include passport, medical reports, and hospital invitation.

• Update tests: AMH/FSH, AFC ultrasound, STD screen; semen analysis and infectious disease panel.
• Optimize weight, sleep, nutrition; stop smoking/alcohol excess; take folic acid as advised.
• Align travel dates with stimulation windows; arrange stay near the clinic and plan for follow-ups.

• Medication adherence (luteal support), follow-up labs and scans, mental health support as needed.
• If negative, review cycle data and consider FET or protocol modifications; if positive, arrange ongoing antenatal care.